Article Details
Retrieved on: 2022-05-15 14:38:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Cresco Labs (CRLBF) — Has 174.3% upside due to rapid revenue growth and a 2022 profitable exercise that should make the shares of this cannabis stock ...
Article found on: investorplace.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here